The efficacy of 99mtc-hig for sentinel lymph node mapping in breast cancer patients

Nuclear Medicine Communications

Volumn 26, Issue 9, 2005, Pages 781-786

  Gencoglu, Esra Arzu ^a   Yalcn, Hulya ^a   Yagmurdur, Mahmut ^a   Ozen, Aynur ^a   Basaran, Ozgur ^a   Karakayal, Feza ^a   Ekici, Yahya ^a   Karakayal, Hamdi ^a   Aktas, Ayse ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Gamma probe; Lymphoscintigraphy; Sentinel lymph node

Indexed keywords

ISOSULFAN BLUE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; TECHNETIUM HUMAN IMMUNOGLOBULIN TC 99M; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; IMMUNOGLOBULIN; TECHNETIUM; TECHNETIUM TC 99M IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EARLY CANCER; FEMALE; HUMAN; LYMPHOSCINTIGRAPHY; SCINTISCANNING; SENTINEL LYMPH NODE; TUMOR BIOPSY; BREAST TUMOR; CLINICAL TRIAL; LYMPH NODE; LYMPH NODE METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOGLOBULINS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM;

EID: 24044510809     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000173300.86891.43     Document Type: Article

References (34)

1. Pelosi E, Baiocca C, Ala A, Gay E, Bello M, Varetto M, et al. Lymphatic mapping in early stage breast cancer: comparison between periareolar and subdermal injection. Nucl Med Commun 2003; 24:519-523.
2. Uren RF, Thompson JF, Howman-Giles R. Sentinel lymph node biopsy in patients with melanoma and breast cancer. Int Med J 2001; 31:547-553.
3. Trifiro G, Viale G, Gentilini O, Travaini LL, Paganelli G. Sentinel node detection in preoperative axillary staging. Eur J Nucl Med 2004; 31:46-55.
4. Allweis TM, Badriyyah M, Bar Ad V, Cohen T, Freund HR. Current controversies in sentinel lymph node biopsy for breast cancer. The Breast 2003; 12:163-171.
5. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186:275-283.
6. Maffioli L, Sturm E, Roselli M, Fontanelli R, Pauwels E, Bombradieri E. State of the art of sentinel node biopsy in oncology. Tumori 2000; 86:263-272.
7. Tuttle TM. Techniqual advances in sentinel lymph node biopsy for breast cancer. Am Surg 2004; 70:407-413.
8. Alazraki NP, Styblo T, Grant SF, Cohen C, Larsen T, Aarsvoid JN. Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma-detecting probe. Semin Nucl Med 2000; 30:56-64.
9. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel node in breast cancer using gamma probe. Surg Oncol 1993; 2:335-340.
10. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220:391-401.
11. Albertini JJ, Lyman GH, Cox C, Yeatman T. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276:1818-1822.
12. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995; 36:1175-1180.
13. Veronesi U, Paganelli G, Galimberti V, Zurrida S, Bedoni M, Costa A, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349:1864-1867.
14. Eshima D, Fauconnier T, Eshima L, Thornback JR. Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. Semin Nucl Med 2000; 30:25-32.
15. Aras G, Arýcan P, Cam R, Kucuk NO, Ibis E, Tuzuner A, et al. Identification of sentinel lymph node in breast cancer by lymphoscintigraphy and surgical gamma probe with peritumoral injection of scintigramammographic agent Tc-99m MIBI. Ann Nucl Med 2002; 16:121-126.
16. Ergun EL, Bozkurt MF, Ercan MT, Ruacan S, þener B, Unsal IS. Detection of inflammatory lymph nodes in rabbits by Tc-99m-HIG lymphoscintigraphy. Nucl Med Commun 2002; 23:1177-1182.
17. Svensson W, Glass DM, Bradley D, Peters AM. Measurement of lymphatic function with technetium-99m-labelled polyclonal immunoglobulin. Eur J Nucl Med 1999; 26:504-510.
18. Fowler JC, Solanki CK, Barber RW, Swift EA, Guenther I, Ballinger JR, et al. Measurement of the extraction fractions of nanocolloid and polyclonal immunoglobulin by axillary lymph nodes in patients with breast cancer. Nucl Med Commun 2004; 25:935-940.
19. O'Mahony S, Rose SL, Chilvers AJ, Ballinger JR, Solanki CK, Barber RW, et al. Finding an optimal method for imaging lymphatic vessels of the upper limb. Eur J Nucl Med Mol Imaging 2004; 31:555-563.
20. Pain SJ, Barber RW, Ballinger JR, Solanki CK, O'Mahony S, Mortimer PS, et al. Side to side symmetry of radioprotein transfer from tissue space to systemic vasculature following subcutaneous injection in normal subjects and patients with breast cancer. Eur J Nucl Med Mol Imaging 2003; 30:657-661.
21. Pain SJ, Nicholas RS, Barber RW, Ballinger JR, Purushotham AD, Mortimer PS, et al. Quantification of lymphatic function for investigation of lymphedema: Depot clearance and rate of appearance of soluble macromolecules in blood. J Nucl Med 2002; 43:318-324.
22. Chu KU, Giuliano AE. Potential and pitfalls of sentinel node detection in breast cancer. Recent Results In: Cancer Research 2000; 157:237-249.
23. Bostick PJ, Giuliano AE. Vital dyes in sentinel node localization. Semin Nucl Med 2000; 30:18-24.
24. Morita ET, Chang JC, Leong SPL. Principles and controversies in lymphoscintigraphy with emphasis on breast cancer. Surg Clin N Am 2000; 80:1721-1739.
25. Edreira MM, Colombo LL, Perez JH, Sajaroff EO, de Castigla SG. In vivo evaluation of three different Tc-99m labelled radiopharmaceuticals for sentinel lymph node identification. Nucl Med Commun 2001; 22:499-504.
26. Winchester DJ, Sener SF, Winchester DP, Perlman RM, Goldschmidt RA, Motykie G, et al. Sentinel lymphadenectomy for breast cancer: experience with 180 consecutive patients: efficacy of filtered Tc-99m sulfur colloid with overnight migration time. J Am Coll Surg 1999; 188:597-603.
27. Feldman SM, Krag DN, McNally RK, Moor BB, Weaver DL, Klein P. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg 1999; 188:248-254.
28. Sutton R, Kollias J, Prasad V, Chatterton B, Gill PG. Same-day lymphoscintigraphy and sentinel lymph node biopsy for early breast cancer. ANZ J Surg 2002; 72:542-546.
29. O'Hea BJ, Hill ADK, El-Shirbiny AM, Yeh SDJ, Rosen PP, Coit DG, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan Kettering Cancer Centre. J Am Coll Surg 1998; 186:423-427.
30. Offdile R, Hoh C, Barsky SH, Nelson SD, Elashoff R, Eilber FR, et al. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabelled dextran. Cancer 1998; 82:1704-1708.
31. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 226:645-653.
32. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EFI, Bo van Diest PJ, et al. Impact of lymphoscintigraphy on sentinel node identification with Tc-99m colloidal albumin in breast cancer. J Nucl Med 1997; 38:366-368.
33. Shons A, Joseph E, Cox CE. Predictions of sentinel lymph node metastasis in the lymphatic mapping of breast cancer patients [Abstract]. Breast Cancer Res Treat 1997; 46:24.
34. Crossin JA, Johnson AC, Stewart PB, Turner WW Jr. Gamma probe-guided resection of the sentinel lymph node in breast cancer. Am Surg 1998; 64:666-668.